Actively Recruiting
Evaluating Oral Food Challenges with Alpha-gal Knock Out and Wild Type Pork to Diagnose Alpha-Gal Syndrome
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-10-08
160
Participants Needed
4
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a multisite, randomized, double-blind, controlled crossover trial to study Alpha-gal Syndrome AGS, a condition involving allergic reactions to a carbohydrate found in red meat. The study aims to compare reactions to alpha-gal Knock Out KO pork versus Wild Type WT pork by evaluating oral food challenges in participants with different clinical subtypes of AGS. This Phase 2 trial is designed to better understand the diagnostic process for AGS. Participants undergo two oral food challenges in a randomized order, serving as their own controls. They will ingest 150 grams of either alpha-gal KO pork or WT pork on separate days, with at least an 8-day washout period between challenges. The crossover design means each participant receives both types of pork in different sequences to compare reactions under double-blind conditions. During the study, participants will be assessed by the results of the double-blind food challenges, including symptom evaluations and specific scores such as the Gastrointestinal Symptom Rating Scale for Irritable Bowel Syndrome and the Urticaria Activity Score over the week following each challenge. The primary outcome is the occurrence of positive challenge results. The trial includes training on self-administration of epinephrine and monitoring for safety. The entire study period includes the challenges and follow-up assessments within about two months after screening.
CONDITIONS
Brief Title
Beginning to Assess an Appropriate CONtrol for Oral Food Challenges in Alpha-Gal Syndrome (CoFAR-13) - BeACON4AG
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here